Live Breaking News & Updates on Davidr Weber

Stay updated with breaking news from Davidr weber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inozyme Pharma Announces Dosing of First Infant with ENPP1 Deficiency in a Phase 1b Trial of INZ-701

BOSTON, June 27, 2023 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, ....

United States , Kurt Gunter , Matt Pera , Davidr Weber , Inozyme Pharma , Stefan Riley , Bone Health , Corporate Communications , Division Of Endocrinology , Deficiency Program Updates , Inozyme Pharma Inc , Exchange Commission , Medical Director , Private Securities Litigation Reform Act , Annual Report ,